APO Research

APO RESEARCH · REPORT

Value-based Healthcare Service

Selected research

Market Analysis & Forecast

Global Value-based Healthcare Service Market Analysis and Forecast 2026-2032

Market perspective

The global Value-based Healthcare Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Value-based Healthcare Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Value-based Healthcare Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Value-based Healthcare Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Value-based Healthcare Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Value-based Healthcare Service include UnitedHealth Group, Optum, CVS Health, Humana, Kaiser Permanente, Intermountain Health, Mayo Clinic, Cleveland Clinic and Ascension Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Value-based Healthcare Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Value-based Healthcare Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Value-based Healthcare Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Value-based Healthcare Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Value-based Healthcare Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Value-based Healthcare Service revenue, projected growth trends, production technology, application and end-user industry.

Value-based Healthcare Service Segment by Company

UnitedHealth Group

Optum

CVS Health

Humana

Kaiser Permanente

Intermountain Health

Mayo Clinic

Cleveland Clinic

Ascension Health

HCA Healthcare

Tenet Healthcare

Cigna

Aetna

Elevance Health

Blue Cross Blue Shield Association

NHS England

Ramsay Health Care

Bupa

Teladoc Health

Ping An Healthcare

Alibaba Health

WeDoctor

Value-based Healthcare Service Segment by Type

Bundled Payment

Capitation

Outcome-Based Payment

Shared Savings Model

Value-based Healthcare Service Segment by Application

Corporate Insured

Public Insurance

Others

Value-based Healthcare Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Value-based Healthcare Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Value-based Healthcare Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Value-based Healthcare Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Value-based Healthcare Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Value-based Healthcare Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Value-based Healthcare Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Value-based Healthcare Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bundled Payment Major Player Table 3. Capitation Major Player Table 4. Outcome-Based Payment Major Player Table 5. Shared Savings Model Major Player Table 6. Global Value-based Healthcare Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Corporate Insured Major Player Table 8. Public Insurance Major Player Table 9. Others Major Player Table 10. Value-based Healthcare Service Industry Trends Table 11. Value-based Healthcare Service Industry Drivers Table 12. Value-based Healthcare Service Industry Opportunities and Challenges Table 13. Value-based Healthcare Service Industry Restraints Table 14. Global Value-based Healthcare Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Value-based Healthcare Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Value-based Healthcare Service Market Share by Region (2021-2026) Table 17. Global Value-based Healthcare Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Value-based Healthcare Service Market Share by Region (2027-2032) Table 19. Global Value-based Healthcare Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Value-based Healthcare Service Revenue Market Share by Players (2021-2026) Table 21. Global Value-based Healthcare Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Value-based Healthcare Service Key Players Headquarters & Area Served Table 23. Global Value-based Healthcare Service Players, Product Type & Application Table 24. Global Value-based Healthcare Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Value-based Healthcare Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Value-based Healthcare Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Value-based Healthcare Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Value-based Healthcare Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Value-based Healthcare Service Revenue Market Share by Type (2021-2026) Table 31. Global Value-based Healthcare Service Revenue Market Share by Type (2027-2032) Table 32. Global Value-based Healthcare Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Value-based Healthcare Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Value-based Healthcare Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Value-based Healthcare Service Revenue Market Share by Application (2021-2026) Table 36. Global Value-based Healthcare Service Revenue Market Share by Application (2027-2032) Table 37. UnitedHealth Group Company Information Table 38. UnitedHealth Group Business Overview Table 39. UnitedHealth Group Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. UnitedHealth Group Value-based Healthcare Service Product Portfolio Table 41. UnitedHealth Group Recent Development Table 42. Optum Company Information Table 43. Optum Business Overview Table 44. Optum Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Optum Value-based Healthcare Service Product Portfolio Table 46. Optum Recent Development Table 47. CVS Health Company Information Table 48. CVS Health Business Overview Table 49. CVS Health Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. CVS Health Value-based Healthcare Service Product Portfolio Table 51. CVS Health Recent Development Table 52. Humana Company Information Table 53. Humana Business Overview Table 54. Humana Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Humana Value-based Healthcare Service Product Portfolio Table 56. Humana Recent Development Table 57. Kaiser Permanente Company Information Table 58. Kaiser Permanente Business Overview Table 59. Kaiser Permanente Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Kaiser Permanente Value-based Healthcare Service Product Portfolio Table 61. Kaiser Permanente Recent Development Table 62. Intermountain Health Company Information Table 63. Intermountain Health Business Overview Table 64. Intermountain Health Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Intermountain Health Value-based Healthcare Service Product Portfolio Table 66. Intermountain Health Recent Development Table 67. Mayo Clinic Company Information Table 68. Mayo Clinic Business Overview Table 69. Mayo Clinic Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Mayo Clinic Value-based Healthcare Service Product Portfolio Table 71. Mayo Clinic Recent Development Table 72. Cleveland Clinic Company Information Table 73. Cleveland Clinic Business Overview Table 74. Cleveland Clinic Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Cleveland Clinic Value-based Healthcare Service Product Portfolio Table 76. Cleveland Clinic Recent Development Table 77. Ascension Health Company Information Table 78. Ascension Health Business Overview Table 79. Ascension Health Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Ascension Health Value-based Healthcare Service Product Portfolio Table 81. Ascension Health Recent Development Table 82. HCA Healthcare Company Information Table 83. HCA Healthcare Business Overview Table 84. HCA Healthcare Value-based Healthcare Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. HCA Healthcare Value-based Healthcare Service Product Portfolio Table 86. HCA Healthcare Recent Development Table 87. Tenet Healthcare Company Information Table 88. Tenet Healthcare Business Overview Table 89. Tenet Healthcare Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Tenet Healthcare Value-based Healthcare Service Product Portfolio Table 91. Tenet Healthcare Recent Development Table 92. Cigna Company Information Table 93. Cigna Business Overview Table 94. Cigna Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Cigna Value-based Healthcare Service Product Portfolio Table 96. Cigna Recent Development Table 97. Aetna Company Information Table 98. Aetna Business Overview Table 99. Aetna Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Aetna Value-based Healthcare Service Product Portfolio Table 101. Aetna Recent Development Table 102. Elevance Health Company Information Table 103. Elevance Health Business Overview Table 104. Elevance Health Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Elevance Health Value-based Healthcare Service Product Portfolio Table 106. Elevance Health Recent Development Table 107. Blue Cross Blue Shield Association Company Information Table 108. Blue Cross Blue Shield Association Business Overview Table 109. Blue Cross Blue Shield Association Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Blue Cross Blue Shield Association Value-based Healthcare Service Product Portfolio Table 111. Blue Cross Blue Shield Association Recent Development Table 112. NHS England Company Information Table 113. NHS England Business Overview Table 114. NHS England Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. NHS England Value-based Healthcare Service Product Portfolio Table 116. NHS England Recent Development Table 117. Ramsay Health Care Company Information Table 118. Ramsay Health Care Business Overview Table 119. Ramsay Health Care Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Ramsay Health Care Value-based Healthcare Service Product Portfolio Table 121. Ramsay Health Care Recent Development Table 122. Bupa Company Information Table 123. Bupa Business Overview Table 124. Bupa Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Bupa Value-based Healthcare Service Product Portfolio Table 126. Bupa Recent Development Table 127. Teladoc Health Company Information Table 128. Teladoc Health Business Overview Table 129. Teladoc Health Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Teladoc Health Value-based Healthcare Service Product Portfolio Table 131. Teladoc Health Recent Development Table 132. Ping An Healthcare Company Information Table 133. Ping An Healthcare Business Overview Table 134. Ping An Healthcare Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Ping An Healthcare Value-based Healthcare Service Product Portfolio Table 136. Ping An Healthcare Recent Development Table 137. Alibaba Health Company Information Table 138. Alibaba Health Business Overview Table 139. Alibaba Health Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Alibaba Health Value-based Healthcare Service Product Portfolio Table 141. Alibaba Health Recent Development Table 142. WeDoctor Company Information Table 143. WeDoctor Business Overview Table 144. WeDoctor Value-based Healthcare Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. WeDoctor Value-based Healthcare Service Product Portfolio Table 146. WeDoctor Recent Development Table 147. North America Value-based Healthcare Service Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Value-based Healthcare Service Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Value-based Healthcare Service Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Value-based Healthcare Service Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Value-based Healthcare Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. North America Value-based Healthcare Service Revenue by Country (2021-2026) & (US$ Million) Table 153. North America Value-based Healthcare Service Revenue by Country (US$ Million) & (2027-2032) Table 154. Europe Value-based Healthcare Service Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Value-based Healthcare Service Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Value-based Healthcare Service Revenue by Application (2021-2026) & (US$ Million) Table 157. Europe Value-based Healthcare Service Revenue by Application (2027-2032) & (US$ Million) Table 158. Europe Value-based Healthcare Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Value-based Healthcare Service Revenue by Country (2021-2026) & (US$ Million) Table 160. Europe Value-based Healthcare Service Revenue by Country (US$ Million) & (2027-2032) Table 161. China Value-based Healthcare Service Revenue by Type (2021-2026) & (US$ Million) Table 162. China Value-based Healthcare Service Revenue by Type (2027-2032) & (US$ Million) Table 163. China Value-based Healthcare Service Revenue by Application (2021-2026) & (US$ Million) Table 164. China Value-based Healthcare Service Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Value-based Healthcare Service Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Value-based Healthcare Service Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Value-based Healthcare Service Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Value-based Healthcare Service Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Value-based Healthcare Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Value-based Healthcare Service Revenue by Region (US$ Million) & (2021-2026) Table 171. Asia Value-based Healthcare Service Revenue by Region (US$ Million) & (2027-2032) Table 172. SAMEA Value-based Healthcare Service Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Value-based Healthcare Service Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Value-based Healthcare Service Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Value-based Healthcare Service Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Value-based Healthcare Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. SAMEA Value-based Healthcare Service Revenue by Country (2021-2026) & (US$ Million) Table 178. SAMEA Value-based Healthcare Service Revenue by Country (US$ Million) & (2027-2032) Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Value-based Healthcare Service Image Figure 2. Global Value-based Healthcare Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Value-based Healthcare Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bundled Payment Image Figure 5. Capitation Image Figure 6. Outcome-Based Payment Image Figure 7. Shared Savings Model Image Figure 8. Global Value-based Healthcare Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Value-based Healthcare Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Corporate Insured Image Figure 11. Public Insurance Image Figure 12. Others Image Figure 13. Global Value-based Healthcare Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Value-based Healthcare Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Value-based Healthcare Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Value-based Healthcare Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Value-based Healthcare Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Value-based Healthcare Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Value-based Healthcare Service Revenue Market Share by Type (2021-2032) Figure 21. Global Value-based Healthcare Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Value-based Healthcare Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Value-based Healthcare Service Revenue Market Share by Application (2021-2032) Figure 24. North America Value-based Healthcare Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Value-based Healthcare Service Revenue Share by Type (2021-2032) Figure 26. North America Value-based Healthcare Service Revenue Share by Application (2021-2032) Figure 27. North America Value-based Healthcare Service Revenue Share by Country (2021-2032) Figure 28. United States Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Value-based Healthcare Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Value-based Healthcare Service Revenue Share by Type (2021-2032) Figure 33. Europe Value-based Healthcare Service Revenue Share by Application (2021-2032) Figure 34. Europe Value-based Healthcare Service Revenue Share by Country (2021-2032) Figure 35. Germany Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Value-based Healthcare Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Value-based Healthcare Service Revenue Share by Type (2021-2032) Figure 45. China Value-based Healthcare Service Revenue Share by Application (2021-2032) Figure 46. Asia Value-based Healthcare Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Value-based Healthcare Service Revenue Share by Type (2021-2032) Figure 48. Asia Value-based Healthcare Service Revenue Share by Application (2021-2032) Figure 49. Asia Value-based Healthcare Service Revenue Share by Region (2021-2032) Figure 50. Japan Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Value-based Healthcare Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Value-based Healthcare Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Value-based Healthcare Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Value-based Healthcare Service Revenue Share by Country (2021-2032) Figure 60. Brazil Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Value-based Healthcare Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Bundled Payment
  • Capitation
  • Outcome-Based Payment
  • Shared Savings Model
Applications
  • Corporate Insured
  • Public Insurance
  • Others
Companies covered
  • UnitedHealth Group
  • Optum
  • CVS Health
  • Humana
  • Kaiser Permanente
  • Intermountain Health
  • Mayo Clinic
  • Cleveland Clinic
  • Ascension Health
  • HCA Healthcare
  • Tenet Healthcare
  • Cigna
  • Aetna
  • Elevance Health
  • Blue Cross Blue Shield Association
  • NHS England
  • Ramsay Health Care
  • Bupa
  • Teladoc Health
  • Ping An Healthcare
  • Alibaba Health
  • WeDoctor

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Value-based Healthcare Service Market by Type
  3. 1.2.1 Global Value-based Healthcare Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bundled Payment
  5. 1.2.3 Capitation
  6. 1.2.4 Outcome-Based Payment
  7. 1.2.5 Shared Savings Model
  8. 1.3 Value-based Healthcare Service Market by Application
  9. 1.3.1 Global Value-based Healthcare Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Corporate Insured
  11. 1.3.3 Public Insurance
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Value-based Healthcare Service Market Dynamics
  1. 2.1 Value-based Healthcare Service Industry Trends
  2. 2.2 Value-based Healthcare Service Industry Drivers
  3. 2.3 Value-based Healthcare Service Industry Opportunities and Challenges
  4. 2.4 Value-based Healthcare Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Value-based Healthcare Service Market Perspective (2021-2032)
  2. 3.2 Global Value-based Healthcare Service Growth Trends by Region
  3. 3.2.1 Global Value-based Healthcare Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Value-based Healthcare Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Value-based Healthcare Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Value-based Healthcare Service Revenue by Players
  2. 4.1.1 Global Value-based Healthcare Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Value-based Healthcare Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Value-based Healthcare Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Value-based Healthcare Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Value-based Healthcare Service Key Players Headquarters & Area Served
  7. 4.4 Global Value-based Healthcare Service Players, Product Type & Application
  8. 4.5 Global Value-based Healthcare Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Value-based Healthcare Service Market CR5 and HHI
  11. 4.6.3 2025 Value-based Healthcare Service Tier 1, Tier 2, and Tier 3
5 Value-based Healthcare Service Market Size by Type
  1. 5.1 Global Value-based Healthcare Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Value-based Healthcare Service Revenue by Type (2021-2032)
  3. 5.3 Global Value-based Healthcare Service Revenue Market Share by Type (2021-2032)
6 Value-based Healthcare Service Market Size by Application
  1. 6.1 Global Value-based Healthcare Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Value-based Healthcare Service Revenue by Application (2021-2032)
  3. 6.3 Global Value-based Healthcare Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 UnitedHealth Group
  2. 7.1.1 UnitedHealth Group Company Information
  3. 7.1.2 UnitedHealth Group Business Overview
  4. 7.1.3 UnitedHealth Group Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 UnitedHealth Group Value-based Healthcare Service Product Portfolio
  6. 7.1.5 UnitedHealth Group Recent Developments
  7. 7.2 Optum
  8. 7.2.1 Optum Company Information
  9. 7.2.2 Optum Business Overview
  10. 7.2.3 Optum Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Optum Value-based Healthcare Service Product Portfolio
  12. 7.2.5 Optum Recent Developments
  13. 7.3 CVS Health
  14. 7.3.1 CVS Health Company Information
  15. 7.3.2 CVS Health Business Overview
  16. 7.3.3 CVS Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CVS Health Value-based Healthcare Service Product Portfolio
  18. 7.3.5 CVS Health Recent Developments
  19. 7.4 Humana
  20. 7.4.1 Humana Company Information
  21. 7.4.2 Humana Business Overview
  22. 7.4.3 Humana Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Humana Value-based Healthcare Service Product Portfolio
  24. 7.4.5 Humana Recent Developments
  25. 7.5 Kaiser Permanente
  26. 7.5.1 Kaiser Permanente Company Information
  27. 7.5.2 Kaiser Permanente Business Overview
  28. 7.5.3 Kaiser Permanente Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Kaiser Permanente Value-based Healthcare Service Product Portfolio
  30. 7.5.5 Kaiser Permanente Recent Developments
  31. 7.6 Intermountain Health
  32. 7.6.1 Intermountain Health Company Information
  33. 7.6.2 Intermountain Health Business Overview
  34. 7.6.3 Intermountain Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Intermountain Health Value-based Healthcare Service Product Portfolio
  36. 7.6.5 Intermountain Health Recent Developments
  37. 7.7 Mayo Clinic
  38. 7.7.1 Mayo Clinic Company Information
  39. 7.7.2 Mayo Clinic Business Overview
  40. 7.7.3 Mayo Clinic Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mayo Clinic Value-based Healthcare Service Product Portfolio
  42. 7.7.5 Mayo Clinic Recent Developments
  43. 7.8 Cleveland Clinic
  44. 7.8.1 Cleveland Clinic Company Information
  45. 7.8.2 Cleveland Clinic Business Overview
  46. 7.8.3 Cleveland Clinic Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cleveland Clinic Value-based Healthcare Service Product Portfolio
  48. 7.8.5 Cleveland Clinic Recent Developments
  49. 7.9 Ascension Health
  50. 7.9.1 Ascension Health Company Information
  51. 7.9.2 Ascension Health Business Overview
  52. 7.9.3 Ascension Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Ascension Health Value-based Healthcare Service Product Portfolio
  54. 7.9.5 Ascension Health Recent Developments
  55. 7.10 HCA Healthcare
  56. 7.10.1 HCA Healthcare Company Information
  57. 7.10.2 HCA Healthcare Business Overview
  58. 7.10.3 HCA Healthcare Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 HCA Healthcare Value-based Healthcare Service Product Portfolio
  60. 7.10.5 HCA Healthcare Recent Developments
  61. 7.11 Tenet Healthcare
  62. 7.11.1 Tenet Healthcare Company Information
  63. 7.11.2 Tenet Healthcare Business Overview
  64. 7.11.3 Tenet Healthcare Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Tenet Healthcare Value-based Healthcare Service Product Portfolio
  66. 7.11.5 Tenet Healthcare Recent Developments
  67. 7.12 Cigna
  68. 7.12.1 Cigna Company Information
  69. 7.12.2 Cigna Business Overview
  70. 7.12.3 Cigna Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Cigna Value-based Healthcare Service Product Portfolio
  72. 7.12.5 Cigna Recent Developments
  73. 7.13 Aetna
  74. 7.13.1 Aetna Company Information
  75. 7.13.2 Aetna Business Overview
  76. 7.13.3 Aetna Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Aetna Value-based Healthcare Service Product Portfolio
  78. 7.13.5 Aetna Recent Developments
  79. 7.14 Elevance Health
  80. 7.14.1 Elevance Health Company Information
  81. 7.14.2 Elevance Health Business Overview
  82. 7.14.3 Elevance Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Elevance Health Value-based Healthcare Service Product Portfolio
  84. 7.14.5 Elevance Health Recent Developments
  85. 7.15 Blue Cross Blue Shield Association
  86. 7.15.1 Blue Cross Blue Shield Association Company Information
  87. 7.15.2 Blue Cross Blue Shield Association Business Overview
  88. 7.15.3 Blue Cross Blue Shield Association Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Blue Cross Blue Shield Association Value-based Healthcare Service Product Portfolio
  90. 7.15.5 Blue Cross Blue Shield Association Recent Developments
  91. 7.16 NHS England
  92. 7.16.1 NHS England Company Information
  93. 7.16.2 NHS England Business Overview
  94. 7.16.3 NHS England Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 NHS England Value-based Healthcare Service Product Portfolio
  96. 7.16.5 NHS England Recent Developments
  97. 7.17 Ramsay Health Care
  98. 7.17.1 Ramsay Health Care Company Information
  99. 7.17.2 Ramsay Health Care Business Overview
  100. 7.17.3 Ramsay Health Care Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Ramsay Health Care Value-based Healthcare Service Product Portfolio
  102. 7.17.5 Ramsay Health Care Recent Developments
  103. 7.18 Bupa
  104. 7.18.1 Bupa Company Information
  105. 7.18.2 Bupa Business Overview
  106. 7.18.3 Bupa Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Bupa Value-based Healthcare Service Product Portfolio
  108. 7.18.5 Bupa Recent Developments
  109. 7.19 Teladoc Health
  110. 7.19.1 Teladoc Health Company Information
  111. 7.19.2 Teladoc Health Business Overview
  112. 7.19.3 Teladoc Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Teladoc Health Value-based Healthcare Service Product Portfolio
  114. 7.19.5 Teladoc Health Recent Developments
  115. 7.20 Ping An Healthcare
  116. 7.20.1 Ping An Healthcare Company Information
  117. 7.20.2 Ping An Healthcare Business Overview
  118. 7.20.3 Ping An Healthcare Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Ping An Healthcare Value-based Healthcare Service Product Portfolio
  120. 7.20.5 Ping An Healthcare Recent Developments
  121. 7.21 Alibaba Health
  122. 7.21.1 Alibaba Health Company Information
  123. 7.21.2 Alibaba Health Business Overview
  124. 7.21.3 Alibaba Health Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Alibaba Health Value-based Healthcare Service Product Portfolio
  126. 7.21.5 Alibaba Health Recent Developments
  127. 7.22 WeDoctor
  128. 7.22.1 WeDoctor Company Information
  129. 7.22.2 WeDoctor Business Overview
  130. 7.22.3 WeDoctor Value-based Healthcare Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 WeDoctor Value-based Healthcare Service Product Portfolio
  132. 7.22.5 WeDoctor Recent Developments
8 North America
  1. 8.1 North America Value-based Healthcare Service Revenue (2021-2032)
  2. 8.2 North America Value-based Healthcare Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Value-based Healthcare Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Value-based Healthcare Service Revenue by Type (2027-2032)
  5. 8.3 North America Value-based Healthcare Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Value-based Healthcare Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Value-based Healthcare Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Value-based Healthcare Service Revenue by Application (2027-2032)
  9. 8.5 North America Value-based Healthcare Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Value-based Healthcare Service Revenue by Country
  11. 8.6.1 North America Value-based Healthcare Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Value-based Healthcare Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Value-based Healthcare Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Value-based Healthcare Service Revenue (2021-2032)
  2. 9.2 Europe Value-based Healthcare Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Value-based Healthcare Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Value-based Healthcare Service Revenue by Type (2027-2032)
  5. 9.3 Europe Value-based Healthcare Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Value-based Healthcare Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Value-based Healthcare Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Value-based Healthcare Service Revenue by Application (2027-2032)
  9. 9.5 Europe Value-based Healthcare Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Value-based Healthcare Service Revenue by Country
  11. 9.6.1 Europe Value-based Healthcare Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Value-based Healthcare Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Value-based Healthcare Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Value-based Healthcare Service Revenue (2021-2032)
  2. 10.2 China Value-based Healthcare Service Revenue by Type (2021-2032)
  3. 10.2.1 China Value-based Healthcare Service Revenue by Type (2021-2026)
  4. 10.2.2 China Value-based Healthcare Service Revenue by Type (2027-2032)
  5. 10.3 China Value-based Healthcare Service Revenue Share by Type (2021-2032)
  6. 10.4 China Value-based Healthcare Service Revenue by Application (2021-2032)
  7. 10.4.1 China Value-based Healthcare Service Revenue by Application (2021-2026)
  8. 10.4.2 China Value-based Healthcare Service Revenue by Application (2027-2032)
  9. 10.5 China Value-based Healthcare Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Value-based Healthcare Service Revenue (2021-2032)
  2. 11.2 Asia Value-based Healthcare Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Value-based Healthcare Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Value-based Healthcare Service Revenue by Type (2027-2032)
  5. 11.3 Asia Value-based Healthcare Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Value-based Healthcare Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Value-based Healthcare Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Value-based Healthcare Service Revenue by Application (2027-2032)
  9. 11.5 Asia Value-based Healthcare Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Value-based Healthcare Service Revenue by Country
  11. 11.6.1 Asia Value-based Healthcare Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Value-based Healthcare Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Value-based Healthcare Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Value-based Healthcare Service Revenue (2021-2032)
  2. 12.2 SAMEA Value-based Healthcare Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Value-based Healthcare Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Value-based Healthcare Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Value-based Healthcare Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Value-based Healthcare Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Value-based Healthcare Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Value-based Healthcare Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Value-based Healthcare Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Value-based Healthcare Service Revenue by Country
  11. 12.6.1 SAMEA Value-based Healthcare Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Value-based Healthcare Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Value-based Healthcare Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research